Braskem Valuation Multiples

Discover Braskem's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Cydsa, SK Chemicals, Bide Pharmatech Co, SK Discovery Co and more.

Braskem Overview

About Braskem

Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.


Founded

1974

HQ

Brazil

Employees

8.4K

Sectors

Financials (LTM)

Revenue: $14B
EBITDA: $1.6B

EV

$13B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Braskem Financials

Braskem reported last 12-month revenue of $14B and EBITDA of $1.6B.

In the same LTM period, Braskem generated $2.2B in gross profit, $1.6B in EBITDA, and had net loss of ($307M).

Revenue (LTM)


Braskem P&L

In the most recent fiscal year, Braskem reported revenue of $14B and EBITDA of $1.2B.

Braskem is unprofitable as of last fiscal year, with gross margin of 2%, EBITDA margin of 9%, and net margin of (14%).

See analyst estimates for Braskem
LTMLast FY202320242025202620272028
Revenue$14B$14B$14B$15B$14B
Gross Profit$2.2B$305M$581M$1.2B$305M
Gross Margin15%2%4%8%2%
EBITDA$1.6B$1.2B$612M($1.4B)$1.2B
EBITDA Margin11%9%5%(9%)9%
EBIT Margin5%(1%)(2%)1%(1%)
Net Profit($307M)($1.9B)($881M)($2.2B)($1.9B)
Net Margin(2%)(14%)(6%)(15%)(14%)
Net Debt-$11B---

Financial data powered by Morningstar, Inc.

Braskem Stock Performance

Braskem has current market cap of $743M, and enterprise value of $13B.

Market Cap Evolution


Braskem's stock price is $0.85.

Braskem share price increased by 2.2% in the last 30 days, and decreased by 30.8% in the last year.

Braskem has an EPS (earnings per share) of $-2.23.

See more trading valuation data for Braskem
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$13B$743M1.4%2.2%-30.5%-30.8%$-2.23

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Braskem Valuation Multiples

Braskem trades at 0.9x EV/Revenue multiple, and 7.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Braskem

EV / Revenue (LTM)


Braskem Financial Valuation Multiples

As of September 13, 2026, Braskem has market cap of $743M and EV of $13B.

Braskem has a P/E ratio of (2.4x).

LTMLast FY202320242025202620272028
EV/Revenue0.9x0.9x0.9x0.9x0.9x
EV/EBITDA7.8x10.3x21.0x(9.1x)10.3x
EV/EBIT19.7x(123.0x)(38.2x)74.0x(123.0x)
EV/Gross Profit5.9x42.2x22.1x11.2x42.2x
P/E(2.4x)(0.4x)(0.8x)(0.3x)(0.4x)
EV/FCF(15.1x)(9.0x)(9.8x)(50.4x)(9.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Braskem Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Braskem Margins & Growth Rates

Braskem grew revenue by 8% and EBITDA by 64% in the last fiscal year.

In the most recent fiscal year, Braskem reported gross margin of 2%, EBITDA margin of 9%, and net margin of (14%).

See estimated margins and future growth rates for Braskem

Braskem Margins

Last FY202420252026202720282029
Gross Margin2%8%2%17%
EBITDA Margin9%(9%)9%14%
EBIT Margin(1%)1%(1%)7%
Net Margin(14%)(15%)(14%)3%
FCF Margin(10%)(2%)(10%)(6%)

Braskem Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth8%10%(7%)8%
Gross Profit Growth745%99%(74%)745%
EBITDA Growth64%(331%)(188%)64%
EBIT Growth(1127%)(152%)(160%)(1127%)
Net Profit Growth(120%)147%(11%)(120%)
FCF Growth(38%)(81%)463%(38%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Braskem Operational KPIs

Braskem's revenue per employee in the last FY averaged $1.7M, while opex per employee averaged $0.0M for the same period.

Braskem's Rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Braskem's Rule of X is 33% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Braskem
LTMLast FY202320242025202620272028
Rule of 4012%21%---
Bessemer Rule of X14%33%---
Revenue per Employee-$1.7M---
Opex per Employee-$0.0M---
S&M Expenses to Revenue-3%3%3%3%
G&A Expenses to Revenue-4%4%3%4%
R&D Expenses to Revenue-1%1%1%1%
Opex to Revenue-3%7%7%3%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Braskem Competitors

Braskem competitors include Cydsa, SK Chemicals, Bide Pharmatech Co, SK Discovery Co, Westlake Chemical, Tronox Holdings, Sheela Foam, Explosifs et Produits Chimiques, RHI Magnesita India and AECI.

Most Braskem public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Cydsa1.6x1.5x7.6x5.6x
SK Chemicals1.0x0.9x10.7x10.2x
Bide Pharmatech Co3.2x3.2x18.9x-
SK Discovery Co0.9x-10.7x-
Westlake Chemical1.4x1.3x4.0x3.5x
Tronox Holdings1.4x1.2x264.1x11.6x
Sheela Foam2.2x2.1x18.8x19.0x
Explosifs et Produits Chimiques1.3x1.2x9.2x9.0x

This data is available for Pro users. Sign up to see all Braskem competitors and their valuation data.

Start Free Trial

Acquisitions by Braskem

Braskem has acquired 3 companies to date.

Last acquisition by Braskem was on January 3rd 2023. Braskem acquired taulman3D for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Braskem

taulman3D
Wise Plásticos
Cetrel
Description
taulman3D produces high-performance nylon-based filaments for professional 3D printing across engineering and prototyping uses.
-
Cetrel is a Luxembourg-based industrial waste treatment and recovery specialist serving chemical, pharmaceutical, and manufacturing sectors.
HQ CountryUnited StatesBrazilBrazil
HQ City
-
-
-
Deal Date3 Jan 202322 Aug 202227 Jan 2017
Valuationundisclosed$34M$306M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Braskem acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Braskem

Braskem has invested in 1 company to date.

Latest investment by Braskem was on August 18th 2026. Braskem invested in Braskem Idesa in their $476M Strategic investment round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Braskem

Braskem Idesa
Description
Braskem Idesa is a petrochemical joint venture between Brazilian producer Braskem S.A. and Mexican industrial group Grupo Idesa.
HQ CountryMexico
HQ City
Mexico City
Deal Date18 Aug 2026
RoundStrategic investment
Raised$476M
InvestorsBraskem
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Braskem investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Braskem

When was Braskem founded?Braskem was founded in 1974.
Where is Braskem headquartered?Braskem is headquartered in Brazil.
How many employees does Braskem have?As of today, Braskem has over 8K employees.
Who is the CEO of Braskem?Braskem's CEO is Roberto Prisco Paraíso Ramos.
Is Braskem publicly listed?Yes, Braskem is a public company listed on B3.
What is the stock symbol of Braskem?Braskem trades under BRKM3 ticker.
When did Braskem go public?Braskem went public in 2005.
Who are competitors of Braskem?Braskem main competitors include Cydsa, SK Chemicals, Bide Pharmatech Co, SK Discovery Co, Westlake Chemical, Tronox Holdings, Sheela Foam, Explosifs et Produits Chimiques, RHI Magnesita India, AECI.
What is the current market cap of Braskem?Braskem's current market cap is $743M.
What is the current revenue of Braskem?Braskem's last 12 months revenue is $14B.
What is the current revenue growth of Braskem?Braskem revenue growth (NTM/LTM) is 1%.
What is the current EV/Revenue multiple of Braskem?Current revenue multiple of Braskem is 0.9x.
What is the current EBITDA of Braskem?Braskem's last 12 months EBITDA is $1.6B.
What is Braskem's EBITDA margin?Braskem's last 12 months EBITDA margin is 11%.
What is the current EV/EBITDA multiple of Braskem?Current EBITDA multiple of Braskem is 7.8x.
What is the current FCF of Braskem?Braskem's last 12 months FCF is ($852M).
What is Braskem's FCF margin?Braskem's last 12 months FCF margin is (6%).
What is the current EV/FCF multiple of Braskem?Current FCF multiple of Braskem is (15.1x).
How many companies Braskem has acquired to date?As of September 2026, Braskem has acquired 3 companies.
What was the largest acquisition by Braskem?$306M acquisition of Cetrel on 27th January 2017 was the largest M&A Braskem has done to date.
What companies Braskem acquired?Braskem acquired Cetrel, Wise Plásticos, and taulman3D.
In how many companies Braskem has invested to date?As of September 2026, Braskem has invested in 1 company.
What was the last Braskem investment?On 18th August 2026 Braskem invested in Braskem Idesa, participating in a $476M Strategic investment round.
In what companies Braskem invested in?Braskem invested in Braskem Idesa.

See public comps similar to Braskem

Lists including Braskem

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial